What Does EQRx Do?

Total employees350
HeadquartersCambridge
Founded2019

EQRx, Inc. was a pharmaceutical company founded in 2019 with the ambitious mission to develop and deliver innovative, patent-protected medicines at radically lower prices. The company aimed to re-engineer the drug development and commercialization process to improve global access to important therapies. EQRx focused on creating a pipeline of new chemical entities and biologic drug candidates in high-cost areas like oncology and immunology. In November 2023, EQRx was acquired by Revolution Medicines.

Where Is EQRx's Headquarters?

HQ Function

Served as the central hub for strategic decision-making, research program management, business development, and administrative operations for EQRx's mission to develop and deliver affordable medicines.

Notable Features:

Situated within Kendall Square, a dense cluster of biotech and pharmaceutical companies, offering a modern work environment. Facilities would have been aligned with life science R&D and corporate needs, though specific unique architectural details were not widely publicized.

Work Culture:

EQRx fostered a mission-driven and innovative work culture, attracting individuals passionate about making medicines more affordable. The environment was likely fast-paced, collaborative, and focused on challenging traditional pharmaceutical industry models.

HQ Significance:

The Cambridge location provided EQRx with access to world-class scientific talent, leading research institutions, and a vibrant ecosystem of collaborators, investors, and service providers crucial for its drug development efforts.

Values Reflected in HQ: The choice of a Cambridge HQ underscored EQRx's commitment to cutting-edge science and innovation. The modern facilities likely supported efficiency, collaboration, and the pursuit of its disruptive business model.

Location:

Prior to its acquisition, EQRx aimed for a significant global presence, focusing on making its medicines accessible in major markets worldwide. This involved planning for international regulatory submissions, establishing strategic partnerships, and building out commercial capabilities beyond the US, with an initial focus on regions like Europe.

Street Address:

50 Hampshire Street

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does EQRx Operate Around the World?

London, United Kingdom

Address: Operations were managed through EQRx UK Ltd.; specific public street address for a large office is not widely publicized.

To establish a foothold in Europe, navigate UK and European healthcare systems, and support the company's mission of providing affordable medicines internationally.

Buying Intent Signals for EQRx

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading EQRx? Meet the Executive Team

As of April 2025, EQRx' leadership includes:

Melanie Nallicheri - Former President and Chief Executive Officer
Alexis Borisy - Co-founder and Former Chairman
Sandra Horning, M.D. - Co-founder and Former Head of Product Development & Chief Medical Officer
Jami Rubin - Former Chief Financial Officer
Eric Hedrick, M.D. - Former Chief Physician Executive
Carlos Garcia-Echeverria, Ph.D. - Former Chief of Rx Creation
Kent Rogers - Former Chief Legal Officer and Secretary

Who's Investing in EQRx?

EQRx has been backed by several prominent investors over the years, including:

Andreessen Horowitz
GV (Google Ventures)
ARCH Venture Partners
SoftBank Vision Fund 2
Casdin Capital
Section 32
Nextech Invest
Arboretum Ventures
Verily Life Sciences
Baidu Ventures

What Leadership Changes Has EQRx Seen Recently?

Hire0
Exits10

The 12 months leading up to and including EQRx's acquisition by Revolution Medicines (completed Nov 2023) saw significant executive changes. These were largely driven by strategic restructuring, including major layoffs in May 2023, and culminated in the dissolution of EQRx's independent leadership team upon acquisition.

Departures

Melanie Nallicheri, Departed as CEO of EQRx following the company's acquisition by Revolution Medicines.
Jami Rubin, Departed as CFO of EQRx following the company's acquisition by Revolution Medicines.
Sandra Horning, M.D., Role ceased with EQRx following the company's acquisition by Revolution Medicines; had previously transitioned from day-to-day role but remained involved.

New Appointments:

N/A, No new executive appointments were made to the independent EQRx team in the 12 months leading to its acquisition and wind-down.

What Technology (Tech Stack) Is Used byEQRx?

Discover the tools EQRx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

EQRx Email Formats and Examples

Prior to its acquisition by Revolution Medicines and cessation of independent operations, EQRx, Inc. likely utilized standard corporate email formats. These formats are now historical, and email addresses associated with the @eqrx.com domain are no longer active.

Common formats likely included [first_initial][last]@eqrx.com (e.g., jdoe@eqrx.com) or [first].[last]@eqrx.com (e.g., jane.doe@eqrx.com).

Format

jdoe@eqrx.com

Example

0%

Success rate

What's the Latest News About EQRx?

Revolution MedicinesNovember 10, 2023

EQRx News: Revolution Medicines Completes Acquisition of EQRx

Revolution Medicines announced the successful completion of its all-stock acquisition of EQRx. The transaction aimed to enhance Revolution Medicines' capabilities in developing and commercializing novel cancer therapies....more

GlobeNewswireAugust 1, 2023

EQRx News: Revolution Medicines to Acquire EQRx, Inc.

Revolution Medicines and EQRx announced they entered into a definitive agreement for Revolution Medicines to acquire EQRx in an all-stock transaction, positioning Revolution Medicines to build a fully integrated oncology company....more

Fierce BiotechMay 9, 2023

EQRx News: EQRx Lays Off 170 Staffers, Drops Two Assets, Abandons Original Drug Pricing Mission

EQRx announced a significant restructuring, including laying off 170 employees (54% of its workforce) and discontinuing two cancer drug candidates. This marked a strategic shift away from its initial broad focus on radically lower drug prices towards a more conventional R&D model prior to its acquisition....more

Fierce Biotech (referencing launch)January 12, 2020

EQRx News: EQRx Launched with $200M Series A to Disrupt Drug Pricing Model

EQRx officially launched with $200 million in Series A financing, co-founded by Alexis Borisy. The company's stated goal was to create affordable versions of patent-protected innovative medicines....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including EQRx, are just a search away.